Microbot Medical MBOT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's additional paid-in capital?
- Microbot Medical (MBOT) reported additional paid-in capital of $181.19M in Q1 2026.
- How has Microbot Medical's additional paid-in capital changed year-over-year?
- Microbot Medical's additional paid-in capital increased by 48.3% year-over-year, from $122.15M to $181.19M.
- What is the long-term trend for Microbot Medical's additional paid-in capital?
- Over 5 years (2020 to 2025), Microbot Medical's additional paid-in capital has grown at a 21.4% compound annual growth rate (CAGR), from $68.52M to $180.97M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.